Revvity Q3 FY2026 results
$154.39−1.67%
Revvity reported revenue of $729 million, up 4.3% from a year earlier, net income of $62.3 million and diluted earnings per share of $0.56 against $0.40 for the third quarter of fiscal 2026 (the three months to 4 Oct 2026).
From its quarterly report, the results first announced on 3 Nov 2026. Compiled and checked by AapWire.
Q3 FY2026 against Q3 FY2025
Three months to 4 Oct 2026, against the three months to 28 Sep 2025. Amounts in USD.
| Measure | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | $728.9M | $698.9M | +4.3% |
| Gross profit | $418.6M | $374.6M | +11.7% |
| Gross margin | 57.4% | 53.6% | +3.8 pts |
| Operating income | $95.14M | $81.90M | +16.2% |
| Operating margin | 13.1% | 11.7% | +1.3 pts |
| Net income | $62.30M | $46.65M | +33.5% |
| Diluted EPS | $0.56 | $0.40 | +40.0% |
| Operating cash flow | $166.7M | $138.5M | +20.4% |
| Capital expenditure | $14.35M | $18.50M | −22.5% |
| Free cash flow | $152.4M | $120.0M | +27.0% |
Operating KPIs for the quarter
| KPI | Q3 FY2026 | Change on a year |
|---|---|---|
| Product revenue | $596.8M | up 4.1% |
| Service revenue | $132.1M | up 5.1% |
| Life Sciences revenue | $379.6M | up 10.7% |
| Diagnostics revenue | $349.3M | down 1.9% |
| Americas revenue | $341.9M | up 11.3% |
| Europe revenue | $220.8M | up 9.1% |
| Asia revenue | $166.2M | down 12.2% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | 4 Oct 2026 | $728.9M | +4.3% | $0.56 |
| Q2 FY2026 | 5 Jul 2026 | $729.7M | +1.3% | $0.47 |
| Q1 FY2026 | 5 Apr 2026 | $711.1M | +7.0% | $0.36 |
| Q4 FY2025 | 28 Dec 2025 | $772.1M | +5.9% | $0.87 |
| Q3 FY2025 | 28 Sep 2025 | $698.9M | +2.2% | $0.40 |
| Q2 FY2025 | 29 Jun 2025 | $720.3M | +4.1% | $0.46 |
| Q1 FY2025 | 30 Mar 2025 | $664.8M | +2.3% | $0.35 |
| Q4 FY2024 | 29 Dec 2024 | $729.4M | +4.8% | $0.78 |
More on Revvity: financial statements · revenue · earnings per share
RVTY's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.